Advertisement

International Journal of Clinical Pharmacy

, Volume 38, Issue 4, pp 784–787 | Cite as

Identification of patients with atrial fibrillation in UK community pharmacy: an evaluation of a new service

  • M. J. TwiggEmail author
  • T. Thornley
  • N. Scobie
Short Research Report

Abstract

Background Many patients with atrial fibrillation (AF) are asymptomatic and diagnosed via opportunistic screening. Community pharmacy has been advocated as a potential resource for opportunistic screening and lifestyle interventions. Objective The objective of this evaluation is to describe the outcomes from an AF service, in terms of referrals and interventions provided to patients identified as not at risk. Methods Eligibility was assessed from pharmacy records and the completion of a short questionnaire. Once consented, patients were screened for AF and their blood pressure was measured. Results Of 594 patients screened, nine were identified as at risk of having AF and were referred to their GP. The service also identified 109 patients with undiagnosed hypertension, 176 patients with a Body Mass Index >30, 131 with an Audit-C score >5 and 59 smokers. Pharmacists provided 413 interventions in 326 patients aimed at weight reduction (239), alcohol consumption (123) and smoking cessation (51). Conclusion This evaluation characterises the interventions provided to, not only those identified with the target condition—in this case AF—but also those without it. The true outcome of these additional interventions, along with appropriate follow-up, should be the focus of future studies.

Keywords

Atrial fibrillation Community pharmacy Pharmacy services Risk assessment United Kingdom 

Notes

Acknowledgments

The authors wish to thank the pharmacists who provided the service.

Funding

The implementation of this service was funded by Alphega pharmacy and the pharmacists received no additional payment for providing it to their patients.

Conflicts of interest

None.

References

  1. 1.
    Lip GYH, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379(9816):648–61.CrossRefPubMedGoogle Scholar
  2. 2.
    Brüggenjürgen B, Rossnagel K, Roll S, Andersson FL, Selim D, Müller-Nordhorn J, et al. The impact of atrial fibrillation on the cost of stroke: the Berlin acute stroke study. Value Health. 2007;10(2):137–43.CrossRefPubMedGoogle Scholar
  3. 3.
    Le Page P, MacLachlan H, Anderson L, Penn L-A, Moss A, Mitchell AR. The efficacy of a smartphone ECG application for cardiac screening in an unselected island population. Br J Cardiol. 2015;22:31–3.CrossRefGoogle Scholar
  4. 4.
    Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167–76.CrossRefPubMedGoogle Scholar
  5. 5.
    Department of Health. Pharmacy in England: building on strengths—delivering the future. London: The Stationery Office; 2008. ISBN 978-0-10-173412-7.Google Scholar
  6. 6.
    Twigg MJ, Wright DJ, Thornley T, Haynes L. Community pharmacy type 2 diabetes risk assessment: demographics and risk results. Int J Pharm Pract. 2015;23(1):80–2.CrossRefPubMedGoogle Scholar
  7. 7.
    Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS ONE. 2014;9(4):e91157.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, for the Ambulatory Care Quality Improvement P. The audit alcohol consumption questions (audit-c): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789–95.CrossRefPubMedGoogle Scholar
  9. 9.
    Hobbs R, Fitzmaurice D, Jowett S, Mant J, Murray E. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over: the SAFE study. Health Technol Assess. 2005;9(40):90.CrossRefGoogle Scholar
  10. 10.
    Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing 2016

Authors and Affiliations

  1. 1.School of PharmacyUniversity of East AngliaNorwichUK
  2. 2.D90 EF08, Boots UKBeeston, NottinghamUK
  3. 3.Alphega Pharmacy UKSurreyUK

Personalised recommendations